Taken together, our results indicate that local tumor treatment with carefully selected immunomodulatory cytokine (such as IFN-α2, IFN-γ and IL-2) can result in favorable alteration of tumor microenvironment and thus affect T-cell activity within the tumor. Here, IFNA2 is linked to neoplasm.